Next Article in Journal
Variability of Non-Polar Secondary Metabolites in the Red Alga Portieria
Next Article in Special Issue
A New Diketopiperazine, Cyclo-(4-S-hydroxy-R-proline-R-isoleucine), from an Australian Specimen of the Sponge Stelletta sp.
Previous Article in Journal
Tetrodotoxin Sensitivity of the Vertebrate Cardiac Na+ Current
Previous Article in Special Issue
Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition
Review

Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites

1
Department of Pharmacognosy, School of Pharmacy, University of Mississippi, MS 38677, USA
2
National Centre for Aquatic Biodiversity and Biosecurity, National Institute of Water and Atmospheric Research Ltd., Auckland Central 1149, New Zealand
*
Author to whom correspondence should be addressed.
Mar. Drugs 2011, 9(11), 2423-2437; https://doi.org/10.3390/md9112423
Received: 22 September 2011 / Revised: 9 November 2011 / Accepted: 11 November 2011 / Published: 21 November 2011
(This article belongs to the Special Issue Bioactive Compound from Marine Sponges)
Porifera have long been a reservoir for the discovery of bioactive compounds and drug discovery. Most research in the area has focused on sponges from tropical and temperate waters, but more recently the focus has shifted to the less accessible colder waters of the Antarctic and, to a lesser extent, the Arctic. The Antarctic region in particular has been a more popular location for natural products discovery and has provided promising candidates for drug development. This article reviews groups of bioactive compounds that have been isolated and reported from the southern reaches of the Arctic Circle, surveys the known sponge diversity present in the Arctic waters, and details a recent sponge collection by our group in the Aleutian Islands, Alaska. The collection has yielded previously undescribed sponge species along with primary activity against opportunistic infectious diseases, malaria, and HCV. The discovery of new sponge species and bioactive crude extracts gives optimism for the isolation of new bioactive compounds from a relatively unexplored source. View Full-Text
Keywords: bioactive molecules; Porifera; sponges; Alaskan Arctic; Aleutian Islands bioactive molecules; Porifera; sponges; Alaskan Arctic; Aleutian Islands
Show Figures

MDPI and ACS Style

Abbas, S.; Kelly, M.; Bowling, J.; Sims, J.; Waters, A.; Hamann, M. Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites. Mar. Drugs 2011, 9, 2423-2437. https://doi.org/10.3390/md9112423

AMA Style

Abbas S, Kelly M, Bowling J, Sims J, Waters A, Hamann M. Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites. Marine Drugs. 2011; 9(11):2423-2437. https://doi.org/10.3390/md9112423

Chicago/Turabian Style

Abbas, Samuel, Michelle Kelly, John Bowling, James Sims, Amanda Waters, and Mark Hamann. 2011. "Advancement into the Arctic Region for Bioactive Sponge Secondary Metabolites" Marine Drugs 9, no. 11: 2423-2437. https://doi.org/10.3390/md9112423

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop